Latest News

Scientific Roundtable Focuses Efforts on Leiomyosarcoma Research


 

Research clinicians from the US and abroad participated in a scientific research roundtable this past September to establish the most important issues facing leiomyosarcoma (LMS) research and clinical trials. The workshop, expected to be an annual event, is a joint effort of the National Leiomyosarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).

The roundtable’s mission is to bring together sarcoma experts for a meeting dedicated to LMS, where participants discuss the present state of LMS and the continued challenges of diagnosis and treatment. Its goal is to develop working plans to close the gaps in LMS patient care and improve LMS patient-care protocols. They also advise the NLMSF on worthy and important research projects that deserve the foundation’s future funding efforts.

Plans for roundtable meetings in 2020 and 2021 are already underway. Between the annual meetings, workgroups continue to take steps toward addressing the issues identified by the roundtable. For more information on the roundtable and NLMSF, visit: https://nlmsf.org.

Recommended Reading

Onodera’s Prognostic Nutritional Index in soft tissue sarcoma patients as a predictor of wound complications
MDedge Hematology and Oncology
Soft Tissue Sarcoma: Diagnosis and Treatment
MDedge Hematology and Oncology
Uterine sarcoma: Professional resources from the National Cancer Institute
MDedge Hematology and Oncology
Targetable genetic alterations found in 41% of soft tissue sarcomas
MDedge Hematology and Oncology
Trabectedin bests supportive care in advanced soft-tissue sarcomas
MDedge Hematology and Oncology
Predicting treatment response in leiomyosarcoma, liposarcoma
MDedge Hematology and Oncology